GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 817 filers reported holding GLAXOSMITHKLINE PLC in Q3 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $402,000 | -29.7% | 9,226 | -29.7% | 0.00% | -20.0% |
| Q1 2022 | $572,000 | -17.6% | 13,121 | -16.6% | 0.01% | -16.7% |
| Q4 2021 | $694,000 | -31.8% | 15,738 | -40.9% | 0.01% | -33.3% |
| Q3 2021 | $1,018,000 | +17.1% | 26,635 | +22.1% | 0.01% | +28.6% |
| Q2 2021 | $869,000 | +11.0% | 21,812 | -0.6% | 0.01% | 0.0% |
| Q1 2021 | $783,000 | -14.7% | 21,936 | -12.0% | 0.01% | -22.2% |
| Q4 2020 | $918,000 | -32.9% | 24,935 | -31.4% | 0.01% | -40.0% |
| Q3 2020 | $1,368,000 | -15.6% | 36,337 | -8.5% | 0.02% | -16.7% |
| Q2 2020 | $1,620,000 | +21.8% | 39,720 | +13.2% | 0.02% | +12.5% |
| Q1 2020 | $1,330,000 | -19.2% | 35,093 | +0.2% | 0.02% | +23.1% |
| Q4 2019 | $1,647,000 | -9.1% | 35,040 | -17.4% | 0.01% | -13.3% |
| Q3 2019 | $1,811,000 | +11.1% | 42,440 | +4.2% | 0.02% | +25.0% |
| Q2 2019 | $1,630,000 | -13.7% | 40,740 | -9.8% | 0.01% | -14.3% |
| Q1 2019 | $1,888,000 | – | 45,180 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |